Alkermes Plc (ALKS)
47.03
+0.05
(+0.11%)
USD |
NASDAQ |
Nov 13, 16:00
47.02
-0.01
(-0.02%)
Pre-Market: 19:59
Alkermes EPS Diluted (Quarterly) : 0.0924 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0924 |
| June 30, 2026 | 0.0029 |
| March 31, 2026 | -0.40 |
| December 31, 2025 | 0.291 |
| September 30, 2025 | 0.4911 |
| June 30, 2025 | 0.5173 |
| March 31, 2025 | 0.1331 |
| December 31, 2024 | 0.8796 |
| September 30, 2024 | 0.5531 |
| June 30, 2024 | 0.5343 |
| March 31, 2024 | 0.2129 |
| December 31, 2023 | 0.6629 |
| September 30, 2023 | 0.2778 |
| June 30, 2023 | 1.382 |
| March 31, 2023 | -0.2535 |
| December 31, 2022 | -0.1719 |
| September 30, 2022 | -0.3894 |
| June 30, 2022 | -0.1839 |
| March 31, 2022 | -0.221 |
| December 31, 2021 | 0.0054 |
| September 30, 2021 | -0.1795 |
| June 30, 2021 | 0.0147 |
| March 31, 2021 | -0.1404 |
| December 31, 2020 | -0.2679 |
| September 30, 2020 | -0.0008 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.1852 |
| March 31, 2020 | -0.2445 |
| December 31, 2019 | -0.034 |
| September 30, 2019 | -0.3364 |
| June 30, 2019 | -0.2675 |
| March 31, 2019 | -0.6166 |
| December 31, 2018 | -0.0625 |
| September 30, 2018 | -0.22 |
| June 30, 2018 | -0.21 |
| March 31, 2018 | -0.40 |
| December 31, 2017 | -0.06 |
| September 30, 2017 | -0.24 |
| June 30, 2017 | -0.28 |
| March 31, 2017 | -0.45 |
| December 31, 2016 | -0.14 |
| September 30, 2016 | -0.41 |
| June 30, 2016 | -0.31 |
| March 31, 2016 | -0.51 |
| December 31, 2015 | -0.46 |
| September 30, 2015 | -0.54 |
| June 30, 2015 | -0.31 |
| March 31, 2015 | -0.21 |
| December 31, 2014 | 0.20 |
| September 30, 2014 | -0.27 |
| June 30, 2014 | 0.0242 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | 0.0114 |
| Prothena Corp. Plc | -0.321 |
| Cue Biopharma, Inc. | -24.14 |
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 16.29M |
| Revenue (Quarterly) | 480.13M |
| Total Expenses (Quarterly) | 463.84M |
| Enterprise Value | 8.718B |
| Gross Profit Margin (Quarterly) | 75.88% |
| Profit Margin (Quarterly) | 3.39% |
| Earnings Yield | -0.03% |
| Operating Earnings Yield | 1.15% |
| Normalized Earnings Yield | 0.2148 |